6533b86cfe1ef96bd12c8954

RESEARCH PRODUCT

Responsiveness and minimal important difference of the urticaria control test

Karsten WellerMarcus MaurerBediha BolukbasiAdriane Peveling-oberhagTorsten ZuberbierPetra StaubachTatevik OhanyanTomasz HawroNicole SchoepkeMartin Metz

subject

medicine.medical_specialtybusiness.industryImmunologyTreatment outcomeOmalizumabDisease controlDisease activity030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineChronic disease030228 respiratory systemQuality of lifeControl testInternal medicineSeverity of illnessmedicinePhysical therapyImmunology and Allergysense organsskin and connective tissue diseasesbusinessmedicine.drug

description

This study demonstrates the responsiveness of the Urticaria Control Test (UCT). Changes of its score by 3 points or more reflect a clinically relevant change of disease control (minimal important difference).

yearjournalcountryeditionlanguage
2017-12-01Journal of Allergy and Clinical Immunology
https://doi.org/10.1016/j.jaci.2017.04.050